CVMP opinions on veterinary medicinal products 

The Committee adopted a positive opinion for a marketing authorisation for Cirbloc, for the active immunisation of pigs from three weeks of age to reduce viraemia, virus load in the lungs and lymphoid tissues, and virus shedding caused by porcine circovirus type 2 (PCV2) infection.

The Committee adopted a positive opinion for a marketing authorisation for AviGate S. Typhimurium, for the active immunisation of healthy chickens to reduce faecal excretion and colonisation of internal organs with Salmonella Typhimurium. 

The Committee adopted a positive opinion for a variation for Vectormune HVT-AIV, to add turkeys as a new target species and to increase the minimum titre per dose.

The Committee adopted a positiveopinion for a variation for Firocoxib CP-Pharma (firocoxib), to add horses as a new target species.

The Committee adopted a positive opinion for a variation for Innovax ND-H5, to fulfil the specific obligation…